Harvard The Comprehensive 2023 Gastroenterology Update

Inflammatory Bowel Disease & Biologic Therapy

• Updated guidelines for the use of biologics in IBD
• How to choose which biologic agent to start with
• Therapeutic drug monitoring in IBD treatment
• How to monitor patients during treatment
• When to switch therapies
• New agents available for IBD care
• Managing refractory pouchitis
• Microscopic colitis updates

Infections, Immunotherapy & Microbiome

• Updated guidelines for treatment of C. difficile infection
• When fecal microbiota transplantation is indicated
• GI complications of immunotherapy
• How to approach and treat immunotherapy-related GI disease
• The stool microbiome and clinical applications
• Impact of COVID on GI practice
• New strategies for common GI problems

Liver Disease & Hepatology

• Management of fatty liver disease in 2023
• How to diagnose and manage cirrhosis
• Alcohol-related liver disease
• Autoimmune hepatitis
• Risk stratification in liver disease
• Practical liver disease management strategies
• Evidence-based hepatology updates for daily practice

Esophageal and Upper GI Disorders

• Management of refractory GERD
• Barrett’s esophagus updates
• Eosinophilic esophagitis
• How to decide between drug therapy and dietary therapy in eosinophilic esophagitis
• Upper GI diagnostic and treatment strategies
• Applying updated guidance to chronic esophageal disease

IBS, Pelvic Floor Disorders & Functional GI Care

• Improved management of IBS
• Pelvic floor disorders
• Functional bowel disorder strategies
• Patient-centered management of chronic GI symptoms
• Practical care pathways for common functional GI presentations
• Integration of new evidence into daily GI care

Pancreatic and Small Bowel Disorders

• Acute pancreatitis
• Chronic pancreatitis
• Celiac disease
• Making sense of multiple serologic tests in celiac disease
• New therapeutic strategies on the horizon for celiac disease
• Clinical evaluation of complex pancreatic and small bowel presentations

Colonoscopy Quality, GI Bleeding & Cancer Risk

• How to improve adenoma detection rate
• Why adenoma detection rate is critical to measure
• Steps to ensure delivery of high-quality colonoscopic care
• Techniques to effectively control acute GI bleeding
• Expanded genetic testing options for hereditary GI cancer syndromes
• High risk for colorectal cancer
• Practical strategies for cancer prevention and early detection

Guidelines, Clinical Updates & Future Directions

• Comprehensive update of national guidelines
• Recent advances and their impact on clinical approaches
• Updates that improve patient outcomes
• Practical recommendations for day-to-day GI practice
• Future directions in gastroenterology
• Cutting-edge topics from world-renowned experts

It is ideal for gastroenterologists, internists, hospitalists, primary care physicians, family physicians, GI fellows, residents, NPs, PAs, endoscopy teams, and clinicians involved in digestive and liver disease care.

The course covers IBD, biologics, therapeutic drug monitoring, refractory pouchitis, C. difficile infection, FMT, GI complications of immunotherapy, microscopic colitis, fatty liver disease, cirrhosis, Barrett’s esophagus, eosinophilic esophagitis, IBS, pelvic floor disorders, refractory GERD, acute pancreatitis, chronic pancreatitis, celiac disease, GI bleeding, hereditary GI cancer syndromes, colorectal cancer risk, colonoscopy quality, adenoma detection rate, and COVID impact on GI practice.

Yes. The course focuses on updated guidelines, best practices, practical strategies, and clinical recommendations that can be incorporated into everyday gastroenterology practice.

No. This course package does not include CME points.

You can contact us at support@getmedicalcourses.com.